C12N 2502/1135
Granulocytes
C12N2502/1135 (Granulocytes) appears on 7 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 7
- Published applications
- 7
- Assignees
- 7
- Inventors
- 17
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 2 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 2 |
| 2022 | 1 | 2 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 3 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Production of a bioengineered lung28 Apr 2026US 12,612,602 B2Board of Regents, The University of Texas System
- Methods of producing modified natural killer cells and methods of use21 Oct 2025US 12,448,604 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Process for generating genetically engineered autologous T cells4 Mar 2025US 12,241,086 B2Amgen Inc.
- Oral health model for high throughput screen and characterization of oral hygiene products21 Jan 2025US 12,203,926 B2Colgate-Palmolive Company
- Methods of producing modified natural killer cells and methods of use5 Apr 2022US 11,293,010 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Methods of producing modified natural killer cells and methods of use21 Jul 2022US 2022/0228117 A1The United States of America, as represented by the Secretary, Dept. of Health and Human Services
- Oral Health Model for High Throughput Screen and Characterization of Oral Hygiene Products24 Mar 2022US 2022/0091101 A1Colgate-Palmolive Company
- Process for generating genetically engineered autologous t cells21 Oct 2021US 2021/0324331 A1Amgen Inc.
- Production of a bioengineered lung27 May 2021US 2021/0155904 A1Board of Regents, The University of Texas System
- Methods of producing modified natural killer cells and methods of use1 Mar 2018US 2018/0057795 A1The United States of America, as represented by the Secretary, Department of Health and Human
Most cited
By later US patents